Benchmark Starts Anebulo Pharmaceuticals (ANEB) at Buy

May 25, 2021 6:14 AM EDT Send to a Friend
Benchmark analyst Robert Wasserman initiates coverage on Anebulo Pharmaceuticals (NASDAQ: ANEB) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login